Login
$KDK
$1.13 +$0.09 (8.17%) Live

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses
Other receivables
Marketable securities
Accounts receivable
Prepaid expenses and other current assets
Total current assets
Investments held in Trust Account
Deferred offering costs
Restricted cash
Property and equipment, net
Operating lease right-of-use assets
Other assets
Total assets
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Due to related party
Related Party
Total due to related party
Extension note
Related Party
Total extension note
Working capital loan
Operating lease liabilities, current
Debt, current portion
Second lien loans
Total current liabilities
Deferred financing obligation
Debt, net of current portion
Second lien loans
Liabilities, redeemable convertible preferred stock and stockholders’ deficit
Debt, net of current portion
Deferred underwriting and advisory fees
Simple agreements for future equity
Operating lease liabilities, noncurrent
Common stock warrants
Other liabilities
Total liabilities
Class A ordinary shares subject to possible redemption as of December 31, 2024
Redeemable convertible preferred stock
Series A Cumulative Convertible Preferred Stock
Cumulative redeemable convertible preferred stock
Total redeemable convertible preferred stock
Stockholders’ deficit
Preference shares, $0.0001 par value; 99,990,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value; 1,980,000 shares authorized; 194,1731 and 175,4401 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common Class A
Common Class B
Total common stock, $0.0001 par value; 1,980,000 shares authorized; 194,1731 and 175,4401 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total stockholders’ deficit
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit
Redemption price (in dollars per share)
Outstanding shares subject to redemption (in shares)
Common Class A
Series A Cumulative Convertible Preferred Stock
Cumulative redeemable convertible preferred stock
Total outstanding shares subject to redemption (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support